Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Buyung Poetra Sembada Tbk. (HOKI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Buyung Poetra Sembada Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Buyung Poetra Sembada Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Buyung Poetra Sembada Tbk. trades at Rp56 (market cap 541.95B, 3.55M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Buyung Poetra Sembada Tbk. is more actively traded (3.55M versus 635.5K). Which is the better fit depends on your goals.

HOKILABS
Market Cap
541.95B691.25B
Volume
3.55M635.5K
Lot
35.51K6.36K
Turnover
196.93M110.15M
Average Price
55.45173.33
Value
196.93M110.15M
Indicative Equilibrium Price
56174
Indicative Equilibrium Volume
60250

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HOKI
View details
LABS
View details

About Buyung Poetra Sembada Tbk.

PT Buyung Poetra Sembada Tbk (the “Company”) was established based on Notarial Deed No. 46 ofIchsan Tedjabuana, S.H., dated September 16, 2003.

Read more on HOKI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS